20 years of Cure Parkinson's
We’re here for the cure! This year marks 20 years since Cure Parkinson’s was founded by four people living with Parkinson’s who felt that nobody was taking a cure seriously enough and that there was an urgent need for a focused approach to curative research...
Learn more
New registry Join Parkinson’s Research aims to boost awareness and accessibility of clinical research studies for Parkinson’s
The Join Parkinson’s Research (JPR) registry is a new online platform where people living with the condition can register to hear about the latest clinical studies. Clinical research studies are vital to improve our understanding of Parkinson’s and help develop new treatments. However, due to…
Improving diversity in Parkinson’s research – The East London Parkinson’s Disease Project
The East London Parkinson’s Disease Project (ELPD) is a study led by Professor Alastair Noyce at Queen Mary University London. This Cure Parkinson’s supported initiative seeks to better understand the experiences of people with Parkinson’s from diverse ethnic backgrounds. Recently, the ELPD team published a…
Cure InSight: Cure Parkinson’s Spring/Summer 2025 Newsletter
Download the latest edition of our biannual newsletter, Cure InSight, and find out more about the newest developments in research, fundraising and advocacy for Cure Parkinson’s. Our latest newsletter explores updates from from the phase 3 trial of ambroxol (ASPro-PD) and shares how we’ve been…
Meet the Researcher: Dr Poonam Thakur on prioritising preclinical research
In this new series from Cure Parkinson’s, we’ll be hearing directly from the scientists putting our funded research projects into action. From learning about their career journeys, to getting an inside look at their studies, we’ll discover how their work aims to support people living…
Win a pair of tickets to see Black Sabbath at Villa Park!
Thank you to everyone who took part in our prize draws, together we raised £4,690 towards our search for a cure! Ozzy and Black Sabbath will be supported by heavy metal icons including Metallica, Slayer, Pantera and many more, with profits from the show to…